Gorenjski glasIndependentCenterFactual 85Objective 753 days agoThe board of directors of Krka, a Slovenian company, announced plans to distribute 70% of the 2025 financial year's profit—amounting to nearly €392.6 million—as dividends to shareholders, with the remaining portion allocated to reserves and carried forward to the next fiscal year. The proposed dividend payment of €9.10 per share represents a 10.3% increase compared to the previous year. Dividend payments will begin on July 23, contingent upon shareholder registration status as of the cutoff date. Additionally, the company’s management has been granted authority for the next 36 months to acquire and divest shares, ensuring that ownership does not exceed 10% of the company’s basic capital. The first half of 2026 reported record-breaking performance, with revenue up 7% and operating profit up 20%, while net profit increased by 5% compared to the same period the previous year.
Bias read (Center): The article presents factual information regarding corporate financial decisions and performance metrics without overt ideological framing. While the topic involves corporate governance and economic outcomes, which can have political implications, the tone remains neutral, focusing on objective data
Why factuality (85): The article reports on a shareholder meeting where a decision was made regarding dividend distribution based on the company's financial performance. It provides specific figures such as the profit amount, dividend percentage increase, and details about share buybacks. These figures are consistent wi
Why objectivity (75): The article presents information from the shareholder meeting but does not provide multiple perspectives or contextualize the decisions within broader economic or industry trends. The tone remains formal and informative, but there is a slight bias toward positive outcomes, especially in highlighting
FinanceIndependent🔒CenterFactual 85Objective 70yesterdayThe headline suggests that Novo Nordisk, a pharmaceutical company, now offers a higher dividend yield compared to Krka, another pharmaceutical company in Slovenia. The comparison highlights potential differences in financial performance or shareholder returns between the two firms.
Bias read (Center): The headline presents a factual comparison between two companies' dividend yields without overtly favoring one over the other. It does not include explicit ideological framing or emotional language, maintaining a balanced tone.
Why factuality (85): The article presents a factual comparison between Novo Nordisk and Krka based on dividend yields, which is a standard financial metric. While no primary source document was available, the claim aligns with general market data and cross-source consensus that Novo Nordisk has historically offered high
Why objectivity (70): The article maintains a generally neutral tone by presenting the comparison as an observation rather than an opinion. However, it subtly implies that Novo Nordisk may be a better investment option through the phrasing 'ponuja večji dividendni donos,' which can be seen as slightly favoring one compan
FinanceIndependent🔒Center7 hr. ago Krka confirms records: what was the cash cushion before the dividend payment?The headline suggests that Krka, a Slovenian pharmaceutical company, has confirmed record-breaking performance, specifically highlighting the cash reserves before dividend payments. The article likely discusses financial results, emphasizing the company's strong financial position ahead of distributing dividends to shareholders.
Bias read (Center): The headline appears to focus on financial performance rather than political issues, though it references a company's actions which could have economic implications. There is no clear slant toward either left or right in the phrasing, making the lean center appropriate.
Slovenia
